Delivery Order SPE2DB20D3303-SPE2DB25FA0QM

Award Date 6/24/25
Potential Completion Date 6/25/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,841.09, is for the provision of Sandostatin LAR Depot 30 mg kits. The award has an ultimate completion date of May 30, 2025. The contract is not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Sandostatin LAR Depot 30 mg kits. The $3,914.52 firm fixed-price contract has a period of performance through February 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4568189974 Sandostatin LAR Depot 10 mg kits. The contract has a firm fixed price of $2,030.13 and a completion date of May 9, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,982.88 fixed-price contract is for the delivery of Sandostatin LAR Depot 30 mg kits, a medication used to treat certain endocrine disorders. The contract has a performance period that extends through May 6, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This delivery order award, valued at $27,818.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 30 mg Kits. The contract has an ultimate completion date of September 13, 2024. AmerisourceBergen, as a major pharmaceutical distributor, holds multiple indefinite delivery contracts (IDCs) with DLA and other federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of medical commodities....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $6,631.54 and covers the procurement of Sandostatin LAR Depot 10 mg kits, a specialty medication. The contract has an ultimate completion date of December 27, 2024 and is a firm fixed-price type. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Sandostatin LAR Depot 30 mg kits, a specialty medication. The total ceiling value of the contract is $39,261.06, with a completion date of June 7, 2024. The contract is not designated as a set-aside, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the supply of Sandostatin LAR Depot 30 mg kits, a specialty pharmaceutical product. The fixed-price contract has a ceiling value of $3,914.52 and a period of performance through March 13, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,849.62 firm fixed-price contract is for the supply of Sandostatin LAR Depot 30 mg kits, a specialty medication used to treat certain medical conditions. The contract has an ultimate completion date of November 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 30 mg kits. The contract has a firm fixed price of $15,773.13 and a completion date of September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these specialty medications to support military treatment facilities and other federal healthcare programs. The contract is not set aside and is part of a larger Indefinite...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB25FA0QM
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Sandostatin LAR Depot 30 mg kits. The contract has a firm fixed price of $3,982.88 and a period of performance through June 25, 2025. The award is not set-aside and represents an open competition. AmerisourceBergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the DLA, across a wide range of therapeutic categories. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026.

Generated 9/28/25, 2:07 AM